Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-17

Clinical Trial Update: Preeclampsia: A Marker for Future Cardiovascular Risk in Women [NA]

View source ↗

Summary

A clinical trial evaluating whether preeclampsia serves as a marker for future cardiovascular risk in women has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Preeclampsia, Pregnancy Induced Hypertension | NA | Status: SUSPENDED